|
CA2724774C
(en)
|
2008-05-28 |
2013-06-25 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
EP2499139B1
(en)
|
2009-11-10 |
2013-12-11 |
Pfizer Inc |
N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
AU2011228699B2
(en)
|
2010-03-19 |
2016-05-19 |
Pfizer Inc. |
2,3 dihydro-1H-inden-1-yl- 2,7-diazaspiro [3.5] nonane derivatives and their use as antagonists or inverse agonists of the Ghrelin receptor
|
|
US9006450B2
(en)
*
|
2010-07-01 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
PT2621493T
(pt)
|
2010-09-30 |
2016-11-14 |
Pfizer |
Inibidores de n1-pirazolospirocetona acetil-coa carboxilase
|
|
JP5647356B2
(ja)
|
2010-10-29 |
2014-12-24 |
ファイザー・インク |
Ｎ１／Ｎ２−ラクタムアセチル−ＣｏＡカルボキシラーゼ阻害剤
|
|
GEP20166474B
(en)
|
2011-04-22 |
2016-05-10 |
Pfizer |
Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
|
|
CA2841757A1
(en)
|
2011-07-15 |
2013-01-24 |
Etzer Darout |
Gpr 119 modulators
|
|
JP5647379B2
(ja)
|
2011-07-22 |
2014-12-24 |
ファイザー・インク |
キノリニルグルカゴン受容体モジュレーター
|
|
EP2751116B1
(en)
|
2011-08-31 |
2016-10-12 |
Pfizer Inc |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2776405A1
(en)
|
2011-11-11 |
2014-09-17 |
Pfizer Inc |
2-thiopyrimidinones
|
|
CN104334557A
(zh)
|
2012-04-06 |
2015-02-04 |
辉瑞公司 |
二酰基甘油酰基转移酶2抑制剂
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
JP6110937B2
(ja)
|
2012-05-04 |
2017-04-05 |
ファイザー・インク |
ＡＰＰ、ＢＡＣＥ１、およびＢＡＣＥ２の阻害剤としての複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
US9260455B2
(en)
|
2012-09-20 |
2016-02-16 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014091352A1
(en)
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
JP6162820B2
(ja)
|
2012-12-19 |
2017-07-12 |
ファイザー・インク |
炭素環式および複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
JP2016507551A
(ja)
|
2013-02-13 |
2016-03-10 |
ファイザー・インク |
ヘテロアリール置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
CN105530940A
(zh)
|
2013-09-12 |
2016-04-27 |
辉瑞大药厂 |
乙酰辅酶a羧化酶抑制剂用于治疗寻常痤疮的用途
|
|
ES2665153T3
(es)
|
2013-10-09 |
2018-04-24 |
Pfizer Inc. |
Antagonistas del receptor EP3 de prostaglandina
|
|
TR201809388T4
(tr)
|
2014-03-17 |
2018-07-23 |
Pfizer |
Metabolik ve ilişkili hastalıkların tedavisinde kullanılmaya yönelik diasilgliserol asiltransferaz 2 inhibitörleri.
|
|
WO2015150995A1
(en)
|
2014-04-04 |
2015-10-08 |
Pfizer Inc. |
Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
|
|
SG11201607896YA
(en)
|
2014-04-10 |
2016-10-28 |
Pfizer |
2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
|
|
WO2016041845A1
(en)
*
|
2014-09-17 |
2016-03-24 |
Boehringer Ingelheim International Gmbh |
Tetrahydroisoquinoline derivatives and pharmaceutical compositions useful for the treatment of obesity and diabetes
|
|
WO2016092413A1
(en)
|
2014-12-10 |
2016-06-16 |
Pfizer Inc. |
Indole and indazole compounds that activate ampk
|
|
WO2016103097A1
(en)
|
2014-12-22 |
2016-06-30 |
Pfizer Inc. |
Antagonists of prostaglandin ep3 receptor
|
|
MX382097B
(es)
|
2015-05-05 |
2025-03-13 |
Pfizer |
1-(2-aminoetil)-6-(2-(2-hidroxietoxi)-5-metilfenil)-2-tioxo-2,3-dihidropirimidin-4(1h)-ona, y el uso del mismo para tratar afecciones cardiovasculares.
|
|
EP3303303A1
(en)
|
2015-05-29 |
2018-04-11 |
Pfizer Inc |
Novel heterocyclic compounds as inhibitors of vanin-1 enzyme
|
|
MX389753B
(es)
|
2015-06-17 |
2025-03-20 |
Pfizer |
Compuestos triciclicos y su uso como inhibidores de la fosfodiesterasa
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
AU2016305590A1
(en)
|
2015-08-13 |
2018-02-15 |
Pfizer Inc. |
Bicyclic-fused heteroaryl or aryl compounds
|
|
PL3341367T3
(pl)
|
2015-08-27 |
2021-07-12 |
Pfizer Inc. |
Skondensowane bicyklicznie związki heteroarylowe lub arylowe jako modulatory IRAK4
|
|
WO2017037567A1
(en)
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
|
BR112018003489A2
(pt)
|
2015-09-24 |
2018-09-25 |
Pfizer |
n-[2-(2-amino-6,6-dissubstituído-4,4a,5,6-tetra-hidropirano[3,4-d][1,3]tiazin-8a(8h)-il)-1,3-tiazol-4-il]amidas
|
|
EP3353182A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
WO2017051294A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
|
|
EP3397631B1
(en)
|
2015-12-29 |
2021-04-07 |
Pfizer Inc |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
|
|
WO2017182873A2
(en)
|
2016-04-19 |
2017-10-26 |
Ureka Sarl |
Peptide-oligourea foldamer compounds and methods of their use
|
|
SG11201811161YA
(en)
|
2016-07-14 |
2019-01-30 |
Pfizer |
Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
WO2019133445A1
(en)
|
2017-12-28 |
2019-07-04 |
Inception Ibd, Inc. |
Aminothiazoles as inhibitors of vanin-1
|
|
US11254660B2
(en)
|
2018-08-31 |
2022-02-22 |
Pfizer Inc. |
Combinations for treatment of NASH/NAFLD and related diseases
|
|
WO2020102575A1
(en)
|
2018-11-16 |
2020-05-22 |
Inception Ibd, Inc. |
Heterocyclic aminothiazoles and uses thereof
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
CA3140972C
(en)
|
2019-05-20 |
2024-06-18 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
CN110922372A
(zh)
*
|
2019-11-04 |
2020-03-27 |
天津大学 |
达格列净的氨基酸共晶物及其制备方法
|
|
FI4097099T3
(fi)
|
2020-02-07 |
2024-07-30 |
Gasherbrum Bio Inc |
Heterosyklisiä glp-1-agonisteja
|
|
CN115666558A
(zh)
*
|
2020-05-21 |
2023-01-31 |
盐野义制药株式会社 |
脂肪性肝病的治疗用药物
|
|
EP4490155A1
(en)
|
2022-03-09 |
2025-01-15 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
EP4508047A1
(en)
|
2022-04-14 |
2025-02-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
|
WO2024125602A1
(en)
|
2022-12-15 |
2024-06-20 |
Gasherbrum Bio, Inc. |
Salts and solid forms of a compound having glp-1 agonist activity
|